Can-Fite BioPharma CANF
NYSE CANF
$2.22 +0.04 (+2.07%)
As of: Sep 30, 2026 · 1:10 PM EDT

Can-Fite BioPharma Ltd. (CANF) EBIT Margin (2015 - 2023)

Updated

Can-Fite BioPharma's EBIT Margin was -2456.79% in FY2025, down 1250.56 percentage points from -1206.23% in FY2024.

Analysis

Can-Fite BioPharma Ltd. (CANF) EBIT Margin (2015 - 2023) Analysis & Trends

From FY2015 onward, Can-Fite BioPharma has reported EBIT Margin for 11 years.

  • EBIT Margin shows a five-year change of -603.71 percentage points (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual EBIT Margin in data going back to FY2015.
  • Per Business Quant data, EBIT Margin in earlier years was -1206.23% in FY2024 (-103.27 pp), -1102.96% in FY2023 (unchanged), -1102.96% in FY2022 (+402.55 pp) and -1505.51% in FY2021 (+347.57 pp).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -1,183.23%
Sep 30, 2023 -951.53%
Jun 30, 2023 -910.20%
Mar 31, 2023 -1,383.67%
Dec 31, 2022 -909.23%
Sep 30, 2022 -1,261.27%
Jun 30, 2022 -1,014.71%
Mar 31, 2022 -1,156.10%
Dec 31, 2021 -1,974.51%
Sep 30, 2021 -1,398.41%
Jun 30, 2021 -1,253.20%
Mar 31, 2021 -1,466.89%
Dec 31, 2020 -2,368.67%
Sep 30, 2020 -1,174.88%
Jun 30, 2020 -1,877.94%
Dec 31, 2019 -2,401.56%
Sep 30, 2019 -242.27%
Jun 30, 2019 -1,623.65%
Mar 31, 2019 572.24%
Dec 31, 2018 -866.09%
API Access

Can-Fite BioPharma Ltd. EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CANF&period=max&api_key=YOUR_API_KEY